News

With investments in novel drugs on the decline, the decision on whether or not to use a new product may serve to foster or stunt development.

The 2018-19 US flu season lasted 21 weeks, marking the longest season in a decade.

According to a press release issued by the manufacturer, the products are the therapeutic equivalent to Genentech’s Tamiflu capsules.

A symposium at ASM Microbe 2019 considered some specific examples of how bacteriophage shape the microbiome and also zoomed out for a higher-altitude view of the microbiome.

A look at the latest developments in drugs intended to quell gram-positive pathogens, including Clostridioides difficile and non-tuberculosis mycobacterial infections, as presented at ASM Microbe 2019.

Australian investigators conducted an assessment to determine if cannabidiol was effective at killing a range of gram-positive bacteria.

With the arrival of summer in the United States, health officials are reminding the public to take precautions to avoid West Nile virus.

A new study found that infants fully vaccinated against rotavirus were 33% less likely to develop type 1 diabetes later in life than children who didn’t receive the vaccine.

External female catheter could be 1 strategy to reduce the prevalence of CAUTIs.

Survey results emphasize the value of educating full-time students with science- and health care-focused majors about vaccines.

Here is a look at infectious disease-related US Food and Drug Administration news from the week of June 16, 2019.

We’ve rounded up a list of important US Food and Drug Administration (FDA) and US Department of Agriculture (USDA) recalls from this past week.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

De-escalation to monotherapy upon bacteremia resolution did not result in unfavorable outcome differences compared with those who continued combination therapy.

Bacteria carrying tandem Guiana extended-spectrum β-lactamase enzymes may be an emerging threat in the United States, a new study suggests.

The FDA has expanded the patient population and issued updated drug interactions, warnings, and precautions for Biktarvy.

A recent animal trial reveals that MK-8591 offers protection against SHIV at lower and more infrequent doses than current PrEP options, renewing hope for more choices in the future.

Kaiser Permanente Northern California’s study shows that the pertussis vaccine weakens as time passes after a patient's most recent vaccination.

From biosensors to travel screening efforts, here's how DHS is beefing up biodefense.

Vibrio vulnificus is a serious gram-negative pathogen that can lead to wound and intestinal infections and has high rates of mortality.

The sNDA application is based on positive results from a Phase III, randomized, double-blind, study that compared the efficacy and safety of BAXDELA to moxifloxacin for the treatment of CABP.

The neighboring nation to the DRC has also launched ring vaccination following the confirmation of 3 travel-associated Ebola cases.

A new study finds that age, sex, and site of infection can increase the risk of long-term mortality in the first 5 years following sepsis survival.

We asked those working on the frontlines to share their thoughts on the scope of the problem and possible solutions.

A phase 1 study demonstrated that pembrolizumab is appropriate for FDA-approved indications and clinical trials among people living with HIV and advanced cancer.

It's time to use data technology to help tackle epidemics and pandemic preparedness.

According to the study, the 3 contraceptive methods that were studied had high levels of safety and effectiveness in preventing pregnancy and well received by study participants.

How can we possibly clean our hands with highly contaminated sinks?